Safety and efficacy of liraglutide, 3.0 mg, once daily vs placebo in patients with poor weight loss following metabolic surgery: the BARI-OPTIMISE randomized clinical trial
however, this pattern shifted in 2023 when both T2DM and the second most common diagnosis, hypertension, were surpassed by obesity (47.1%)
If it persists beyond 8 weeks, discuss with your provider about dose adjustment or formulation change
Provider guidance: experienced oversight matters most of all
For skin-lightening goals, oral supplementation at 500 mg daily shows measurable results
As others reported for the microcurrent devices they tested, our tester for the Bio-Therapeutic BT-Sculpt initially experienced a steep learning curve, but once she got the hang of it, she found it easy to use